Anika Therapeutics announces Monovisc PMA news

theflyonthewall.com

Anika Therapeutics announced that it has received correspondence from the Chief Scientific Officer of the Center for Devices and Radiological Health of the U.S. FDA upholding the non-approvable decision for the Monovisc PMA that was previously disclosed. The company had utilized the FDA’s appeal process to continue to discuss the Monovisc PMA with the FDA.

View Comments (0)